A Study of Ixekizumab in Healthy Participants
NCT03848416
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
99
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
BIOLOGICAL:
Ixekizumab
Sponsor
Eli Lilly and Company